Pancreatic Cancer Research

ResearcherKeio UniversityActive in the last 2 years

Eiichiro So

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-2212-9049; OpenAlex author ID A5109372758. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. Clinical utility of comprehensive genomic profiling for advanced pancreatic cancer: insights from real-world data analysis. Co-author DOI 10.1007/s10147-025-02713-5↗
  2. Digital Ischemia and Necrosis: A Rarely Described Complication of Gemcitabine in Pancreatic Adenocarcinoma. Co-author DOI 10.1089/pancan.2017.0012↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Takanori Kanai∥ · 1 shared paper, 2025 · strength 0.22
  2. Hideyuki Hayashi · 1 shared paper, 2025 · strength 0.22
  3. Yasuo Hamamoto · 1 shared paper, 2025 · strength 0.22
  4. Hiroshi Nishihara · 1 shared paper, 2025 · strength 0.22
  5. Andrea Wang‐Gillam · 1 shared paper, 2017 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.